1Lin HL, Liu TY, Wu CW, et al. 2-Methoxyestradiol- induced caspase-3 activation and apoptosis occurs through G (2)/M arrest dependent and independent pathways in gastric carcinoma cells. Cancer, 2001, 92 (3) : 500.
2Kumar AP, Garcia GE, Slaga TJ. 2-methoxyestradiol blocks cell-cycle progression at G (2)/M phase and inhibits growth of human prostate cancer cells. Mol Carcinog, 2001,31(3) :111.
3Schumacher G, Neuhaus P. The physiological estrogen metabolite 2-methoxyestradiol reduces tumor growth and induces apoptosis in human solid tumors. J Cancer Res Clin Oncol, 2001, 127(7) :405.
4Xiao S, Gillespie DG, Baylis C, et al. Effects of estradiol and its metabolites on glomerular endothelial nitric oxide synthesis and mesangial cell growth. Hypertension, 2001,37 : 645.
5Dubey RK, Jackson EK, Keller P J, et al. Estradiol metabolites inhibit endothelin synthesis by an estrogen receptor-independent mechanism. Hypertension, 2001, 37:640.
6Pribluda VS, Gubish ER Jr, Lavallee TM, et al. 2- Methoxyestradiol: an endogenous antiangiogenie and antiproliferative drug candidate. Cancer Metastasis Rev, 2000,19(1-2):173.
7Huober JB, Nakamura S, Meyn R, et al. Oral administration of an estrogen metabolite-induced potentiation of radiation antitumor effects in presence of wild-type p53 in non-small-cell lung cancer. Int J Radiat Oncol Biol Phys, 2000, 48 (4):1127.
8Lippert C, Seeger H, Mueck AO. The effect of endogenous estradiol metabolites on the proliferation of human breast cancer cells. Life Sci, 2003, 72 (8):877.
9Dingli D, Timm M, Russell SJ, et al. Promising preclinical activity of 2-methoxyestradiol in multiple myeloma. Clin Cancer Res, 2002, 8(12):3948.
10Lambert C, Thews O, Biesalski HK, et al. 2-Methoxyestradiol enhances reactive oxygen species formation and increases the efficacy of oxygen radical generating tumor treatment. Eur J Med Res, 2002, 7 (9) :404.
2Giuliano AE, Hawes D, Ballman KV, et al. Association of occultmetastases in sentinel lymph nodes and bone marrow with survivalamong women with early-stage invasive breast cancer[J]. JAMA,2011,306(4):385-393.
3Han G Z,Liu Z J, Shimoi K, et al. Synergism between the anticanceractions of 2-medroxyestradiol and microtubule-disrupting agents inhumanbreast cancer 卩].Cancer Res,2005,65(2):387-393.
4Reiner T, Delas Pozas A, Gomez LA, et al. Low dose combinations of2-medroxyestradiol and docetaxel block prostate cancer cells inmitosis and in crease apoptosis[J]. Cancer Letters,2009,276(l):21-31.
5Xu X,Roman J, IssaqH, et al. Quantitative Measurement of Endoge-nous Estrogens and Estrogen Metabolites in Human Serum by LiquidChroma-tography-T andem Mass Spectrometry [J]. Anal Chem,2007,79:7813-7821.
6Folkman J. Tumor angiogenesis: Therapeutic implications [J]. N Eng JMed,1971,85:1182-1186.
7Avetisov SE, Mamikoian VR, Surguch BK, et al. Antiangiogenictherapy for choroidal neovascularization induced by age-relatde ma-cular dugeneration (preliminary communication)[J]. Vestn of talmol,2009,125(6):3-8.
9Guan Y,Ramasamy Reddy K, Zhu Q, et al. G-rich oligonucl eotidesinhibit HIF-1 alpha and HIF-2alpha and block tumor growth [J].MolTher,2010,18(1):188-197.
10Rey S,Semenza GL. Hypoxia-inducible factor-1 dependent mechani-sms of vascularization and vascular remodeling[J]. Cardiovasc Res,2010,86(2):236-242.
